Home
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

NCT04195347

Conditions: Acute Pancreatitis, Digestive System Diseases, Hematologic Diseases, +12 more
Locations: Novant Health Presbyterian Hemby Children's Hospital Charlotte, North Carolina, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

European Prospective Investigation Into Childhood Cancer

NCT05375617

Conditions: Acute Lymphoblastic Leukemia, Brain Diseases, Brain Neoplasms, +17 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Recruiting

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

NCT03568266

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Recruiting

Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital

NCT06681363

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leucemia, Hematologic Diseases, +11 more
Locations: Nantes University Hospital Nantes, France

View Trial Details

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT04195633

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +59 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

NCT05418088

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +44 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes

NCT06727942

Conditions: Adult ALL, Behavior, Hematologic Diseases, +11 more
Locations: University of Texas at Arlington Movement & Physical Activity Epidemiology Laboratory Arlington, Texas, United States

View Trial Details

Recruiting

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

NCT04881240

Conditions: Acute Lymphoblastic Leukemia, Refractory, Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, +11 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

CARPALL: Immunotherapy With CD19+CD22 CAR T-cells for CD19+ and CD22+ Acute Lymphoblastic Leukaemia

NCT02443831

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Great Ormond Street Hospital London, United Kingdom

University College Hospital London, United Kingdom

Manchester Royal Children's Hospital Manchester, United Kingdom

View Trial Details

Recruiting

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

NCT03263572

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein Expression, +29 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions